Stay updated on Hemostatic Activity Post LAAO Clinical Trial
Sign up to get notified when there's something new on the Hemostatic Activity Post LAAO Clinical Trial page.

Latest updates to the Hemostatic Activity Post LAAO Clinical Trial page
- ChecktodayChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The study record page remains a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoChange DetectedA banner announces NIH website updates and says that, during a transition, some NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with the footer revision updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected study record content. This indicates the page is currently inaccessible, preventing viewing the study details and related information.SummaryDifference16%

- Check64 days agoChange DetectedThe page's revision metadata was updated from v3.6.5 to v3.6.6, indicating a new revision of the study record. This update does not modify substantive study details, eligibility, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Hemostatic Activity Post LAAO Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hemostatic Activity Post LAAO Clinical Trial page.